IMMUCELL CORP /DE/

ICCC · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances
418
SEC Filings

Business Summary

ImmuCell Corporation, founded in 1982, is an animal health biologics company focused on developing, manufacturing, and commercializing products to improve the survivability and health of neonatal dairy and beef calves. Its primary product line, First Defense, uses hyperimmunized bovine colostrum to deliver pathogen-specific antibodies against E. coli, bovine coronavirus, and bovine rotavirus, preventing neonatal calf scours. Products are sold under brand names Dual-Force and Tri-Shield, and the company also offers a California Mastitis Test diagnostic.

Next Earnings

Q2 FY2026 — expected 2026-09-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionICCCdiscussed_in_filing Cybersecurity
topic_mentionICCCdiscussed_in_filing Trusted Computing
topic_mentionICCCdiscussed_in_filing Blockchain & Crypto
topic_mentionICCCdiscussed_in_filing Capital Expenditure
topic_mentionICCCdiscussed_in_filing Supply Chain
topic_mentionICCCdiscussed_in_filing Regulation
topic_mentionICCCdiscussed_in_filing Healthcare & Bio
topic_mentionICCCdiscussed_in_filing Platform & Ecosystem
topic_mentionICCCdiscussed_in_filing Sovereign & Government
topic_mentionICCCdiscussed_in_filing Cybersecurity
topic_mentionICCCdiscussed_in_filing Trusted Computing
topic_mentionICCCdiscussed_in_filing Blockchain & Crypto
topic_mentionICCCdiscussed_in_filing Capital Expenditure
topic_mentionICCCdiscussed_in_filing Supply Chain
topic_mentionICCCdiscussed_in_filing Regulation
topic_mentionICCCdiscussed_in_filing Healthcare & Bio
topic_mentionICCCdiscussed_in_filing Platform & Ecosystem
topic_mentionICCCdiscussed_in_filing Sovereign & Government
topic_mentionICCCdiscussed_in_filing Cybersecurity
topic_mentionICCCdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001437749-26-010339EDGAR39K words
2025-03-282024-12-310001013762-25-004072EDGAR—
2024-04-012023-12-310001213900-24-028718EDGAR—
2023-03-292022-12-310001213900-23-024080EDGAR—
2022-03-302021-12-310001213900-22-016147EDGAR—
2021-03-302020-12-310001213900-21-018473EDGAR—
2020-03-272019-12-310001213900-20-007650EDGAR—
2019-03-222018-12-310001213900-19-004653EDGAR—
2018-03-292017-12-310001213900-18-003621EDGAR—
2017-03-302016-12-310001213900-17-003009EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001437749-25-034817EDGAR45K words
2025-08-142025-06-300001213900-25-076635EDGAR—
2025-05-142025-03-310001213900-25-043287EDGAR—
2024-11-132024-09-300001213900-24-097450EDGAR—
2024-08-132024-06-300001213900-24-068245EDGAR—
2024-05-142024-03-310001213900-24-042925EDGAR—
2023-11-132023-09-300001213900-23-086092EDGAR—
2023-08-102023-06-300001213900-23-065595EDGAR—
2023-05-112023-03-310001213900-23-038529EDGAR—
2022-11-212022-09-300001213900-22-074215EDGAR—
2022-08-112022-06-300001213900-22-046861EDGAR—
2022-05-122022-03-310001213900-22-025936EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-180001437749-26-008842EDGAR1K words
2026-03-040001437749-26-006912EDGAR—
2026-02-090001437749-26-003514EDGAR—
2026-02-020001437749-26-002685EDGAR—
2026-01-080001437749-26-000885EDGAR—
2025-12-290001437749-25-038773EDGAR—
2025-11-130001437749-25-034819EDGAR—
2025-11-040001437749-25-033017EDGAR—
2025-10-070001437749-25-030631EDGAR—
2025-09-300001437749-25-030110EDGAR—

418 total filings indexed. 386 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. TKNO — Alpha Teknova, Inc. AWHL — Aspira Women's Health Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. CLDX — Celldex Therapeutics, Inc. IDXX — IDEXX LABORATORIES INC /DE

Tags

neonatal-dairy-calf-health neonatal-beef-calf-health scours-prevention-(calf-level-market) scours-prevention-(dam-level-market) certified-organic-dairy-and-beef-operations international-animal-health-markets usda-center-for-veterinary-biologics-(virus-serum-toxin-act) u.s.-fda-federal-food,-drug,-and-cosmetic-act canadian-food-inspection-agency organic-materials-review-institute-(omri)-listing

Company Identity

CIK0000811641
TickerICCC
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 4e50cbe393134e3a4b1718ca169ce03a4f4bd4d01de84593f5f644eade02bafd
parent: 94a832b7f8c6dbb28afb74a266651ad09bf58044b9eaf68728463526fa51a0f2
content hash: 7d890fcd1d315de81d4e5538ba1915baca61ab1f51c69ab89a53ac8a550d5bd3
signed: 2026-04-13T04:45:37.141Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf